HomeOLMA • NASDAQ
add
Olema Pharmaceuticals Inc
Previous close
$5.01
Day range
$4.90 - $5.19
Year range
$2.86 - $16.62
Market cap
353.05M USD
Avg Volume
838.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 34.87M | 18.86% |
Net income | -30.39M | 1.88% |
Net profit margin | — | — |
Earnings per share | -0.36 | 35.71% |
EBITDA | -34.74M | -18.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 392.71M | 57.73% |
Total assets | 409.64M | 55.35% |
Total liabilities | 26.19M | -4.34% |
Total equity | 383.45M | — |
Shares outstanding | 68.42M | — |
Price to book | 0.89 | — |
Return on assets | -20.26% | — |
Return on capital | -21.93% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -30.39M | 1.88% |
Cash from operations | -43.98M | -87.18% |
Cash from investing | -45.08M | -123.80% |
Cash from financing | 222.00K | -97.48% |
Net change in cash | -88.84M | -155.15% |
Free cash flow | -32.41M | -339.94% |
About
Founded
2006
Headquarters
Website
Employees
102
